These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17127444)

  • 1. Recent advances in high-throughput molecular marker identification for superficial and invasive bladder cancers.
    Dyrskjot L; Zieger K; Orntoft TF
    Front Biosci; 2007 Jan; 12():2063-73. PubMed ID: 17127444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of high-throughput DNA microarrays to identify biomarkers for bladder cancer.
    Sánchez-Carbayo M
    Clin Chem; 2003 Jan; 49(1):23-31. PubMed ID: 12507957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bladder tumor histoseminar - Introduction. Bladder tumours diagnosis facing new treatments and new molecular classifications].
    Allory Y
    Ann Pathol; 2016 Dec; 36(6):371-372. PubMed ID: 27838083
    [No Abstract]   [Full Text] [Related]  

  • 4. Identifying distinct classes of bladder carcinoma using microarrays.
    Dyrskjøt L; Thykjaer T; Kruhøffer M; Jensen JL; Marcussen N; Hamilton-Dutoit S; Wolf H; Orntoft TF
    Nat Genet; 2003 Jan; 33(1):90-6. PubMed ID: 12469123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical markers in the evaluation of tumors of the urinary bladder: a review.
    Emerson RE; Cheng L
    Anal Quant Cytol Histol; 2005 Dec; 27(6):301-16. PubMed ID: 16450787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.
    Sanchez-Carbayo M; Socci ND; Lozano J; Saint F; Cordon-Cardo C
    J Clin Oncol; 2006 Feb; 24(5):778-89. PubMed ID: 16432078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.
    Dadhania V; Zhang M; Zhang L; Bondaruk J; Majewski T; Siefker-Radtke A; Guo CC; Dinney C; Cogdell DE; Zhang S; Lee S; Lee JG; Weinstein JN; Baggerly K; McConkey D; Czerniak B
    EBioMedicine; 2016 Oct; 12():105-117. PubMed ID: 27612592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of bladder cancer by microarray expression profiling: towards a general clinical use of microarrays in cancer diagnostics.
    Dyrskjøt L
    Expert Rev Mol Diagn; 2003 Sep; 3(5):635-47. PubMed ID: 14510183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress with next-generation biomarkers in muscle-invasive bladder cancer.
    Contreras-Sanz A; Roberts ME; Seiler R; Black PC
    Int J Urol; 2017 Jan; 24(1):7-15. PubMed ID: 27597124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of genetic and cytogenetic alterations in pathological aggressiveness urothelial carcinoma of the bladder: Performance of BCA-1, a mini-array comparative genomic hybridisation-based test].
    Léon P; Cancel Tassin G; Sighar K; Compérat E; Gaffory C; Ondet V; Hugonin S; Audouin M; Doizi S; Traxer O; Ciofu C; Rouprêt M; Lacave R; Cussenot O
    Prog Urol; 2017; 27(8-9):451-457. PubMed ID: 28576425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential PTEN protein expression profiles in superficial versus invasive bladder cancers.
    Koksal IT; Yasar D; Dirice E; Usta MF; Karauzum S; Luleci G; Baykara M; Sanlioglu S
    Urol Int; 2005; 75(2):102-6. PubMed ID: 16123561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular signature in superficial bladder carcinoma predicts clinical outcome.
    Dyrskjøt L; Zieger K; Kruhøffer M; Thykjaer T; Jensen JL; Primdahl H; Aziz N; Marcussen N; Møller K; Orntoft TF
    Clin Cancer Res; 2005 Jun; 11(11):4029-36. PubMed ID: 15930337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene discovery in bladder cancer progression using cDNA microarrays.
    Sanchez-Carbayo M; Socci ND; Lozano JJ; Li W; Charytonowicz E; Belbin TJ; Prystowsky MB; Ortiz AR; Childs G; Cordon-Cardo C
    Am J Pathol; 2003 Aug; 163(2):505-16. PubMed ID: 12875971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.
    Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Kawaoka K; Wong SG; Belldegrun AS; Pantuck AJ
    Cancer; 2009 Apr; 115(7):1448-58. PubMed ID: 19195047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
    Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
    Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in bladder cancer diagnostics.
    Sanchez-Carbayo M
    Clin Biochem; 2004 Jul; 37(7):562-71. PubMed ID: 15234237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of molecular subtyping in bladder cancer.
    Satyal U; Sikder RK; McConkey D; Plimack ER; Abbosh PH
    Curr Opin Urol; 2019 Jul; 29(4):350-356. PubMed ID: 31158107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical markers in the evaluation of tumors of the urinary bladder: a review.
    Requena MJ; Alvarez-Kindelan J; Blanca A
    Anal Quant Cytol Histol; 2007 Dec; 29(6):380-2. PubMed ID: 18225396
    [No Abstract]   [Full Text] [Related]  

  • 19. Bladder cancer: state-of-the-art care.
    Droller MJ
    CA Cancer J Clin; 1998; 48(5):269-84. PubMed ID: 9742894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of gene expression patterns in superficial and invasive human bladder cancers].
    Zhou L; Shi BT; Wang SX; Luo Y; Yang L; Zhang LL; Wang XY; He DL
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):798-801. PubMed ID: 17565857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.